Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSYR for Chemotherapy-Related Fatigue
NCT05229029Phase 2Active, not recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Apr 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ren Shen Yang Rong Tang in cancer-related fatigue (CRF), sponsored by Peking University Cancer Hospital & Institute. Started Apr 2020; status: active, not recruiting.
02
Drugs
Ren Shen Yang Rong Tang
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT05229029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229029.